fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Insulin (zinc crystalline) human biosynthetic (rdna origin)

All injection strengths: general benefit

Humulin Regular · DIN 00586714 · 1000U/10 mL · injection solution-10mL Pk

General benefit; Health Canada lists this DIN as Cancelled post market since 2026-05-25 — choose a marketed DIN from the same-category list.Discontinued May 25, 2026 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-05-25 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-05-25 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Humulin Regular · DIN 00586714 Manufacturer: Eli Lilly Canada Inc.; listing date 1996-10-01 Health Canada: Cancelled post market since 2026-05-25 · brand HUMULIN R · ATC A10AB01 INSULIN (HUMAN) · form Solution · route Intramuscular, Intravenous, Subcutaneous · ingredients INSULIN SEMI SYNTHETIC HUMAN 100 UNIT/ML · company Eli lilly canada inc · schedule Schedule d
Re-check Health Canada status and shortages (live) · Health Canada product record

Humulin Regular: Formulary list price $29.98 per unit (the source does not state the unit; exact figure $29.9800). What the ministry pays, not the patient.

Ministry pays: $29.9800 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00586714)

Source record
DIN 00586714: Humulin Regular Raw flags: insOH=Y, sec3=Y Item: 682010009; group id 768; item number 1873; lccId None; manufacturer id LIL Source form: Inj Sol-10mL Pk; strength: 1000U/10mL Recorded listing: General benefit; diabetes medication flag Source prices (unrounded): $29.9800; ministry $29.9800 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00586714 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5325
Shortage status: discontinued (May 25, 2026, reported by ELI LILLY CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00586714
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 25, 2026 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (A10A, A10AB): coverage varies; not interchangeable

  • Insulin aspart (NovoRapid): general benefit, limited Use 646
  • Insulin glulisine dna origin (Apidra): general benefit
  • Insulin human biosynthetic (Novolin ge Toronto): general benefit
  • Insulin lispro (Humalog): general benefit, limited Use 646
  • Human biosynthetic + insulin (Entuzity KwikPen): general benefit
Other drugs in the same formulary class (68:20:10 Insulins (Rapid Acting)) and how they are covered

Matched class: 68:20:10 Insulins (Rapid Acting)

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: INSULIN GLULISINE (DNA ORIGIN), INSULIN HUMAN BIOSYNTHETIC, INSULIN INJECTION, HUMAN BIOSYNTHETIC Some products covered without a code (check the product listing): INSULIN ASPART, INSULIN LISPRO 68:20:10 Insulins (Rapid Acting)

INSULIN ASPART

· 5 products · Limited Use, codes 646 (1), General benefit (4) · strengths: 100U/mL · Inj Sol-10mL Pk, Inj Sol-10mL Vial Pk, Inj Sol-5x3mL Cart Pk, Inj Sol-5X3mL Pref Pen Pk, Inj Sol-5x3mL SoloSTAR Pref Pen Pk

INSULIN GLULISINE (DNA ORIGIN)

· 3 products · General benefit · strengths: 100U/mL · Inj 5x3mL Cart ClickStar Pen, Inj Sol-10mL Vial, Inj Sol-5x3mL SoloSTAR Pref Pen

INSULIN HUMAN BIOSYNTHETIC

· 2 products · General benefit · strengths: 1000U/10mL, 100U/mL · Inj Sol-10mL Pk, Inj Sol-5x3mL Pk

INSULIN LISPRO

· 5 products · Limited Use, codes 646 (1), General benefit (4) · strengths: 100U/mL, 200U/mL · Inj Sol-10mL Pk, Inj Sol-10mL Vial Pk, Inj Sol-5x3mL Cart Pk, Inj Sol-5x3mL SoloSTAR Pref Pen Pk, Inj Sol-Pref Pen 5x3mL Pk

INSULIN INJECTION, HUMAN BIOSYNTHETIC

· 1 products · General benefit · strengths: 500U/mL · Inj Sol-Pref Pen 2x3mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 68:20:10
Full class listing Related classes: 68:20:02 Oral Anti-Diabetic Agents, 68:20:06 Incretin Mimetics, 68:20:12 Insulins (Intermediate Acting), 68:20:14 Insulins (Long Acting), 68:20:16 Insulins (Pre-Mixed) Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found

Availability

Humulin Regular · DIN 00586714 Shortage status: discontinued (2026-05-25, reported by ELI LILLY CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00586714

Check this DIN again